Pliant Therapeutics Overview
- Founded
- 2016

- Status
- Public
- Employees
- 68

- Stock Symbol
- PLRX

- Share Price
- $31.51
- (As of Friday Closing)
Pliant Therapeutics General Information
Description
Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.
Contact Information
- 260 Littlefield Avenue
- San Francisco, CA 94080
- United States
Pliant Therapeutics Timeline
Pliant Therapeutics Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$31.51 | $32.14 | $19.43 - $43.92 | $1.12B | 35.5M | 119K | $0.75 |
Pliant Therapeutics Financials Summary
In Thousands, USD |
TTM 30-Sep-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 |
---|---|---|---|
EV | 490,743 | ||
Revenue | 94,404 | 57,052 | 0 |
EBITDA | 20,119 | (334) | (30,298) |
Net Income | 19,663 | (631) | (30,276) |
Total Assets | 312,324 | 119,064 | 66,529 |
Total Debt | 384 | 444 | 525 |
Pliant Therapeutics Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Pliant Therapeutics‘s full profile, request access.
Request a free trialPliant Therapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
---|
This information is available in the PitchBook Platform. To explore Pliant Therapeutics‘s full profile, request access.
Request a free trialPliant Therapeutics Comparisons
Industry
00000 00
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialPliant Therapeutics Competitors (16)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Eloxx Pharmaceuticals | Formerly VC-backed | Waltham, MA | 00 | 000.00 | 000000 - 000 | 000.00 |
000000000 | Venture Capital-Backed | Atlanta, GA | 00 | 000.00 | 00000000000 | 000.00 |
00000000 000000000 | Corporation | Norcross, GA | 0 | 000000000000 | ||
0000000 | Venture Capital-Backed | Groningen, Netherlands | 0 | 00000 | 0000000000 0 | 00000 |
000000 00000000000 | Formerly PE-Backed | New York, NY | 000 | 00000 | 000000000 - | 00000 |
Pliant Therapeutics Executive Team (15)
Pliant Therapeutics Board Members (12)
Name | Representing | Role | Since |
---|---|---|---|
Bernard Coulie MD | Pliant Therapeutics | Chief Executive Officer & Board Member | 000 0000 |
Charles Homcy MD | Third Rock Ventures | Board Member | 000 0000 |
David Pyott | Self | Board Member | 000 0000 |
Gayle Crowell | Self | Board Member | 000 0000 |
Hoyoung Huh Ph.D | Self | Board Member | 000 0000 |
Pliant Therapeutics Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialPliant Therapeutics Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Pliant Therapeutics‘s full profile, request access.
Request a free trial